awmsg logo



parathyroid hormone (Natpar®)


Reference No. 2380

Publication date:
08/08/2017


Appraisal information

parathyroid hormone (Natpar®) 25 micrograms powder and solvent for solution for injection
parathyroid hormone (Natpar®) 50 micrograms powder and solvent for solution for injection
parathyroid hormone (Natpar®) 75 micrograms powder and solvent for solution for injection
parathyroid hormone (Natpar®) 100 micrograms powder and solvent for solution for injection
parathyroid hormone (Natpar®) powder and solvent for solution for injection


Company: Shire Pharmaceuticals Ltd
BNF category: Endocrine system
NMG meeting date: Not scheduled
AWMSG meeting date: Not scheduled
   
   
Submission Type: Nonsubmission
Status: Not endorsed
Advice No: Not available
Ratification by Welsh Government: 07/08/2017

Current Progress


Submission
received
NMG
meeting
AWMSG
meeting
Ratification by
Welsh Government

AWMSG advice

In the absence of a submission from the holder of the marketing authorisation, parathyroid hormone (Natpar®) cannot be endorsed for use within NHS Wales for the adjunctive treatment of adult patients with chronic hypoparathyroidism who cannot be adequately controlled with standard therapy alone.
Statement of Advice (SOA)
Download